Chemoinformaics analysis of 9-Aristolen-1alpha-ol
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 220.183 | nRing | 3 |
| Solubility: LogS | -4.118 | nHRing | 0 |
| Solubility: LogP | 4.063 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.62 |
| Synth | 4.656 |
| Natural Product Likeliness | 2.474 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.128 |
| HIA | 0.005 |
| CACO-2 | -4.452 |
| MDCK | 0.000021 |
| BBB | 0.432 |
| PPB | 0.789006 |
| VDSS | 1.479 |
| FU | 0.2127 |
| CYP1A2-inh | 0.281 |
| CYP1A2-sub | 0.39 |
| CYP2c19-inh | 0.132 |
| CYP2c19-sub | 0.845 |
| CYP2c9-inh | 0.074 |
| CYP2c9-sub | 0.472 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.428 |
| CYP3a4-inh | 0.314 |
| CYP3a4-sub | 0.292 |
| CL | 11.261 |
| T12 | 0.081 |
| hERG | 0.029 |
| Ames | 0.01 |
| ROA | 0.954 |
| SkinSen | 0.335 |
| Carcinogencity | 0.322 |
| EI | 0.948 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.038 |
| Antiviral | Yes |
| Prediction | 0.872598 |